Recurrence-free survival | Overall survival | Cancer-specific survival | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | |
Age | 1.010 | 0.996–1.023 | 0.153 | 1.067 | 1.049–1.085 | < 0.001 | 1.052 | 1.027–1.077 | < 0.001 |
BMI (≥24 kg/m2) | 0.834 | 0.623–1.115 | 0.219 | 0.682 | 0.491–0.948 | 0.023 | 0.732 | 0.451–1.189 | 0.207 |
Gender (Female) | 0.832 | 0.592–1.168 | 0.288 | 0.834 | 0.574–1.210 | 0.339 | 0.842 | 0.494–1.437 | 0.529 |
Diabetes mellitus (yes) | 0.930 | 0.599–1.443 | 0.746 | 1.797 | 1.244–2.595 | 0.002 | 2.124 | 1.251–3.606 | 0.005 |
Hypertension (yes) | 1.094 | 0.792–1.510 | 0.586 | 1.022 | 0.717–1.457 | 0.903 | 1.110 | 0.651–1.894 | 0.701 |
ECOG score (≥1) | 2.024 | 1.114–3.678 | 0.021 | 2.031 | 1.456–2.835 | < 0.001 | 1.029 | 0.368–2.877 | 0.956 |
Tumour size | 1.298 | 1.206–1.397 | < 0.001 | 1.256 | 1.150–1.372 | < 0.001 | 1.461 | 1.305–1.635 | < 0.001 |
Fuhrman grade (≥3) | 1.557 | 1.160–2.089 | 0.003 | 0.841 | 0.606–1.167 | 0.299 | 1.128 | 0.699–1.822 | 0.621 |
Pathologic up-staging to T3a | 2.195 | 1.459–3.300 | < 0.001 | 1.632 | 1.029–2.588 | 0.037 | 2.238 | 1.252–4.003 | 0.007 |
Cellular type (non-clear cell) | 0.720 | 0.463–1.119 | 0.144 | 1.120 | 0.699–1.795 | 0.638 | 1.009 | 0.494–2.059 | 0.981 |